Biden Relaunches Cancer Moonshot Initiative
THURSDAY, Feb. 3, 2022 (HealthDay News) — President Joe Biden announced Wednesday that he is giving a new push to the cancer moonshot initiative that he first led during the Obama administration.In his announcement, Biden said the program would aim t…
Learn MoreASA: Stroke Rates Down in Elderly, Up in Young Adults in the U.S.
THURSDAY, Feb. 3, 2022 (HealthDay News) — Although age-standardized stroke burden measures decreased or remained stable from 1990 to 2019 in the United States, the incidence of stroke is increasing among young adults in the South and Midwest, accordi…
Learn MoreKetamine Fast Acting, Effective for Suicidal Ideation
THURSDAY, Feb. 3, 2022 (HealthDay News) — For patients hospitalized with current suicidal ideation, ketamine is effective and safe in the short term, according to a study published online Feb. 2 in The BMJ.
Mocrane Abbar, M.D., from the University of Montpellier in Nîmes, France, and colleagues conducted a prospective trial between April 13, 2015, and March 12, 2019, involving 156 adults with current suicidal ideation admitted to the hospital voluntarily. Participants were randomly assigned to either placebo or ketamine (83 and 73, respectively), stratified by center and diagnosis.
The researchers found that compared with those receiving placebo, more participants receiving ketamine reached full remission of suicidal ideation at day three (63.0 versus 31.6 percent; odds ratio, 3.7; 95 percent confidence interval, 1.9 to 7.3; P
“Whether the emergency use of ketamine for suicidal crises will be recommended in practice depends on many other factors, including the values and preferences of patients, clinicians, researchers, and policymakers,” write the authors of an accompanying editorial.
Several authors disclosed financial ties to the pharmaceutical industry.
Learn MoreAdults With Asthma Compliant With COVID-19 Mask Wearing
THURSDAY, Feb. 3, 2022 (HealthDay News) — Adults with asthma report being compliant with COVID-19-related masking, despite some problematic effects, according to a study published in the January issue of the Journal of Allergy and Clinical Immunology…
Learn MoreNivolumab Combo Treats Advanced Esophageal Squamous-Cell Carcinoma
THURSDAY, Feb. 3, 2022 (HealthDay News) — For patients with previously untreated, advanced esophageal squamous cell carcinoma, treatment with nivolumab plus chemotherapy or nivolumab plus ipilimumab results in significantly longer overall survival th…
Learn MoreASA: Myocardial Infarction May Hasten Cognitive Decline in Adults
THURSDAY, Feb. 3, 2022 (HealthDay News) — Significantly faster declines in global cognition, memory, and executive function are seen following incident myocardial infarction (MI), according to a study presented at the American Stroke Association Inte…
Learn MoreCOVID-19 Convalescent Plasma No Benefit for Most Patients
THURSDAY, Feb. 3, 2022 (HealthDay News) — For the typical patient, COVID-19 convalescent plasma (CCP) is not associated with clinical outcomes, according to a meta-analysis published online Jan. 25 in JAMA Network Open.
Andrea B. Troxel, Sc.D., from the NYU Grossman School of Medicine in New York City, and colleagues compiled individual patient data from randomized clinical trials of CCP and monitored the data in relation to clinical outcomes associated with CCP. Data were obtained from eight international trials, which enrolled 2,369 participants (1,138 randomly assigned to control and 1,231 randomly assigned to CCP). As of April 2021, primary outcome data were available for 2,341 participants.
The researchers found that the median of the World Health Organization (WHO) 11-point ordinal scale was 3 (cumulative odds ratio [OR], 0.94; 95 percent credible interval, 0.74 to 1.19; posterior probability of OR,
“Our results show that, overall, patients hospitalized with COVID-19 may derive modest benefit from convalescent plasma, with some patient subgroups benefiting more than others,” Troxel said in a statement.
Several authors disclosed financial ties to the biopharmaceutical industry.
Learn MoreGuidelines Address Management of Type B Aortic Dissection
THURSDAY, Feb. 3, 2022 (HealthDay News) — In clinical practice guidelines issued by the Society of Thoracic Surgeons and American Association for Thoracic Surgery and published online Jan. 25 in the Annals of Thoracic Surgery and the Journal of Thora…
Learn MoreGroup A Strep Infection Not Tied to Tics in Children With Family History
THURSDAY, Feb. 3, 2022 (HealthDay News) — For children with a first-degree relative with chronic tic disorder (CTD), Group-A streptococcal (GAS) exposure is not associated with tic onset, according to a study published online Feb. 2 in Neurology.Anet…
Learn MoreAberrant Lipid Metabolism ID’d in Early-Stage Lung Cancer
THURSDAY, Feb. 3, 2022 (HealthDay News) — A plasma assay that detects dysregulated lipids has potential as a screening method for early-stage lung cancer, according to a study published in the Feb. 2 issue of Science Translational Medicine.Guangxi Wa…
Learn More